1. Home
  2. BBNX vs HPP Comparison

BBNX vs HPP Comparison

Compare BBNX & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • HPP
  • Stock Information
  • Founded
  • BBNX 2015
  • HPP 2009
  • Country
  • BBNX United States
  • HPP United States
  • Employees
  • BBNX N/A
  • HPP N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • HPP Real Estate
  • Sector
  • BBNX Health Care
  • HPP Finance
  • Exchange
  • BBNX Nasdaq
  • HPP Nasdaq
  • Market Cap
  • BBNX 463.4M
  • HPP 374.6M
  • IPO Year
  • BBNX 2025
  • HPP 2010
  • Fundamental
  • Price
  • BBNX $11.14
  • HPP $2.29
  • Analyst Decision
  • BBNX Strong Buy
  • HPP Hold
  • Analyst Count
  • BBNX 6
  • HPP 10
  • Target Price
  • BBNX $26.67
  • HPP $3.32
  • AVG Volume (30 Days)
  • BBNX 690.5K
  • HPP 3.1M
  • Earning Date
  • BBNX 05-06-2025
  • HPP 05-07-2025
  • Dividend Yield
  • BBNX N/A
  • HPP 2.19%
  • EPS Growth
  • BBNX N/A
  • HPP N/A
  • EPS
  • BBNX N/A
  • HPP N/A
  • Revenue
  • BBNX $65,123,999.00
  • HPP $834,774,000.00
  • Revenue This Year
  • BBNX $29.49
  • HPP N/A
  • Revenue Next Year
  • BBNX $34.93
  • HPP $4.97
  • P/E Ratio
  • BBNX N/A
  • HPP N/A
  • Revenue Growth
  • BBNX 442.93
  • HPP N/A
  • 52 Week Low
  • BBNX $8.89
  • HPP $2.00
  • 52 Week High
  • BBNX $24.50
  • HPP $6.29
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • HPP 38.73
  • Support Level
  • BBNX N/A
  • HPP $2.10
  • Resistance Level
  • BBNX N/A
  • HPP $3.10
  • Average True Range (ATR)
  • BBNX 0.00
  • HPP 0.24
  • MACD
  • BBNX 0.00
  • HPP -0.03
  • Stochastic Oscillator
  • BBNX 0.00
  • HPP 26.36

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: